13D/13G Filings - NeuBase Therapeutics Inc. (NBSE)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-02-14
4:46 pm
Purchase		2023-12-3113GNeuBase Therapeutics, Inc.
NBSE		GREENLIGHT CAPITAL INC136,350
3.700%		136,350increase
(New Position)		Filing
History
2023-09-20
5:28 pm
Sale		2023-09-1413DNeuBase Therapeutics, Inc.
NBSE		Symetryx Corp109,508
3.500%		-363,418decrease
(-76.84%)		Filing
History
2023-09-14
06:03 am
Purchase		2023-09-0813DNeuBase Therapeutics, Inc.
NBSE		Symetryx Corp472,926
9.100%		44,482increase
(+10.38%)		Filing
History
2023-08-31
11:50 am
Purchase		2023-08-2213DNeuBase Therapeutics, Inc.
NBSE		Symetryx Corp428,444
13.800%		428,444increase
(New Position)		Filing
History
2023-01-27
12:49 pm
Purchase		2022-12-2913GNeuBase Therapeutics, Inc.
NBSE		Kershner Trading Americas LLC74,861
4.460%		74,861increase
(New Position)		Filing
History
2022-02-14
3:32 pm
Purchase		2021-12-3113GNeuBase Therapeutics, Inc.
NBSE		GREENLIGHT CAPITAL INC136,351
8.300%		35,000increase
(+34.53%)		Filing
History
2021-02-16
3:40 pm
Purchase		2021-02-1613GNeuBase Therapeutics, Inc.
NBSE		GREENLIGHT CAPITAL INC101,351
8.700%		24,428increase
(+31.76%)		Filing
History
2020-12-29
12:14 pm
Purchase		2020-12-0413GNeuBase Therapeutics, Inc.
NBSE		Kershner Trading Americas LLC66,950
1.000%		66,950increase
(New Position)		Filing
History